{"id":303,"date":"2019-12-08T21:54:30","date_gmt":"2019-12-09T02:54:30","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/6-6-antiarrhythmics\/"},"modified":"2022-12-13T16:23:54","modified_gmt":"2022-12-13T21:23:54","slug":"6-6-antiarrhythmics","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/6-6-antiarrhythmics\/","title":{"raw":"6.6 Antiarrhythmics","rendered":"6.6 Antiarrhythmics"},"content":{"raw":"

Antiarrhythmics<\/h1>\r\nAn arrhythmia is any deviation from the normal rate or pattern of a heartbeat. This includes heart rates that are too slow (bradycardia), too fast (tachycardia), or irregular. The terms dysrhythmia (disturbed heart rhythm) and arrhythmia (absence of heart rhythm) are traditionally used interchangeably in clinical practice despite their difference in meaning.\r\n\r\nThe ECG is used to identify and monitor an arrhythmia. See more information about ECGs in the \"Review of Basic Concepts\" section and an overview of arrhythmias in the \"Common Cardiac Disorders\" section.\r\n\r\nAntiarrhythmic medications regulate heart rate and rhythm by manipulating the conduction of electrical signals to change the heart rate or to attempt to revert an arrhythmia to a normal sinus rhythm. All antiarrhythmic medications have a risk of producing an arrhythmia. Some antiarrhythmic medications are used during emergency situations such as cardiac arrest, whereas others are used long-term, such as those that control atrial fibrillation. Monitoring electrolytes and the ECG patterns are very important assessments for the nurse administering these types of medications.\r\n

Class I - Sodium Channel Blockers<\/h2>\r\nClass I antidysrhythmic medications slow conduction and prolong depolarization by decreasing sodium influx into cardiac cells. There are three subgroups of sodium channel blockers: Class IA, IB, and IC. Quinidine is an example of a Class IA antidysrhythmic. Lidocaine is an example of a Class IB medication that is also used as a local anesthetic. Flecainide is an example of a class IC antidysrhythmic.\r\n

Mechanism of Action<\/h3>\r\nQuinidine slows conduction and prolongs depolarization by decreasing sodium influx into cardiac cells. The conduction rate and automaticity are decreased. This medication also has alpha-antagonistic properties that cause peripheral vasodilation.\r\n

Indications for Use<\/h3>\r\nThis medication is typically used for life-threatening ventricular dysrhythmias such as ventricular tachycardia or for conversion of atrial fibrillation that has not responded to other therapy.\r\n

Nursing Considerations Across the Lifespan<\/h3>\r\nSodium channel blockers are contraindicated in clients who have a history of thrombocytopenia or myasthenia gravis. Use cautiously with clients who have a serious heart block rhythm and do not have an artificial pacemaker, such as a 2nd degree heart block.\r\n\r\nThere is an increased risk for toxicity with clients who have heart failure and renal or hepatic dysfunction due to drug accumulation. This medication's safety has not been thoroughly evaluated in children and geriatric clients. Grapefruit juice should be avoided by clients taking this medication.\r\n

Adverse\/Side Effects<\/h3>\r\nQuinidine may prolong the QT interval leading to ventricular arrhythmias, such as ventricular tachycardia or torsade's de pointes.\r\n\r\nQuinidine may induce thrombocytopenia. Routine lab work may be evaluated by a client's health care provider. Common side effects of this medication are nausea, vomiting, diarrhea, fever, chills, abnormal ECG\/arrhythmias, and headache.\r\n\r\nIn many research trials, use of antiarrhythmic therapy for non-life-threatening arrhythmias actually resulted in increased risk of death compared to placebo.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>. [\/footnote]\r\n

Client Teaching & Education<\/h3>\r\nClient's should be instructed regarding the significance of compliance with therapeutic drug regimen and take medications as prescribed, even if not symptomatic.\u00a0 Client's or family members may need instruction on how to take pulse rate and parameters regarding reporting to their healthcare provider.\r\n\r\nSome antiarrhythmic medications may cause dizziness and may increase sensitivity to light.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n

Class II - Beta Blockers<\/h2>\r\nClass II medications are beta blockers that are used to decrease conduction velocity, automaticity, and the refractory period of the cardiac conduction cycle. Sotalol is a Beta-1 and Beta-2 blocker that also has Class III antiarrhythmic properties. Recall that other types of beta blockers, such as metoprolol, are also used to treat hypertension. See the \"Antihypertensives\" section later in this chapter for more information about the use of beta blockers to treat hypertension.\r\n

Mechanism of Action<\/h3>\r\nSotalol is a non-selective beta-adrenergic blocker that prolongs the cardiac action potential.\r\n

Indications for Use<\/h3>\r\nSotalol is given to clients for life-threatening arrhythmias, such as ventricular arrhythmias or supraventricular arrhythmias. It is not recommended for clients with less than severe arrhythmias.\r\n

Nursing Considerations Across the Lifespan<\/h3>\r\nTitration of this medication is done by evaluating renal function and monitoring QTc on the ECG 2-4 hours after each medication upon initiation.\u00a0 Clients with decreased renal function require dosage adjustment. Sotalol is contraindicated for Clients with decreased serum potassium, bradycardia, 2nd or 3rd-degree heart block, heart failure, and conditions leading to bronchospasm.\r\n

Adverse\/Side Effects<\/h3>\r\nBlack Box Warning: This drug can cause arrhythmias. This medication lengthens a client's QTc interval. Initiation of this medication requires a client to be in a facility to determine baseline QT and intermittent QT interval checks. QT interval checks are done 2-4 hours after each dose. If the QT corrected interval is greater than 500 msec, the dosing must be changed.\r\n\r\nCommon side effects for sotalol are arrhythmias, chest pain, palpitations, fatigue, dizziness, hypotension, bradycardia, heart failure, cardiac ischemia, bronchospasm, thyroid abnormalities, and hypoglycemia. [footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>. [\/footnote]\r\n

Client Teaching & Education<\/h3>\r\nClients should be instructed regarding the significance of compliance with therapeutic drug regimens and should take medications as prescribed, even if not symptomatic.\u00a0 Clients or family members may need instruction on how to take pulse rate and blood pressure. They should receive parameters regarding reporting to their healthcare provider.\u00a0 They should report any pulse rate less than 50 bpm and significant changes in blood pressure.\r\n\r\nClients should also be advised that these medications may cause dizziness and visual changes.\u00a0 Clients may also notice orthostatic blood pressure decrease with position changes and should be advised to change positions slowly.\u00a0 If the client notices irregular, fast heart rate or experiences any fainting episodes, they should notify their healthcare provider immediately.\r\n\r\nAdditionally, these medications may also mask the signs of hypoglycemia, so diabetic clients must use extra caution to monitor for low blood sugar. These medications may also increase cold sensitivity.[footnoteuCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n
Clinical Reasoning and Decision-Making Activity 6.6a\"Image\r\n\r\n<\/header>\r\n
\r\n
    \r\n \t
  1. What should a nurse assess before and after the administration of sotalol?<\/li>\r\n<\/ol>\r\n<\/div>\r\n<\/div>\r\n
    <\/div>\r\n \r\n

    Class IV - Calcium Channel Blockers<\/h2>\r\nClass IV medications include the calcium channel blockers verapamil and diltiazem. These medications increase the refractory period of the AV node by slowing the influx of calcium ions, thus decreasing the ventricular response and the heart rate. This medication may be used to control heart rate associated with supraventricular tachycardias. Calcium channel blockers are also used to treat hypertension because they relax smooth muscle and cause vasodilation. See the \"Anti-hypertensives\" section later in this chapter for more information about their use in treating hypertension.\r\n

    Mechanism of Action<\/h3>\r\nDiltiazem inhibits calcium during depolarization to decrease the workload of the heart and increase oxygen supply to the myocardium. This medication will relax smooth muscle and decrease peripheral resistance.\r\n

    Indications for Use<\/h3>\r\nDiltiazem is used to treat angina, hypertension, and supraventricular tachycardias.\r\n

    Nursing Considerations Across the Lifespan<\/h3>\r\nThis medication is not given to hypotensive clients, clients with acute myocardial infarction, or clients with 2nd or 3rd-degree heart block or sick sinus syndrome.\r\n

    Adverse\/Side Effects<\/h3>\r\nDiltiazem can potentially worsen signs and symptoms of heart failure due to the negative inotropic effect. Clients may experience bradycardia, worsening 1st degree AV block, syncope, edema, hypotension, headache, dizziness, or hepatic injury.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>. [\/footnote]\r\n

    Client Teaching & Education<\/h3>\r\nClients should be advised to closely follow the recommended dosing regimen. Clients or family members may need instruction on how to take a pulse rate and should report any pulse less than 50 bpm. Clients should also be advised that this medication may cause dizziness and visual changes.\u00a0 Clients may also notice orthostatic blood pressure decrease with position changes and should be advised to change positions slowly.\r\n\r\nClients should be advised to avoid grapefruit juice during medication therapy.\u00a0 They should also monitor for gingival sensitivity and be sure to maintain good oral hygiene.\u00a0 Clients may also notice increased photosensitivity and should take protective measures.[footnoteuCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n

    Adenosine<\/h2>\r\nAdenosine is a unique medication given to clients who are experiencing paroxysmal supraventricular tachycardia. It is given all at once as a bolus in either a 6 or 12 mg dose to slow electrical conduction and restore a normal sinus rhythm.\r\n

    Mechanism of Action<\/h3>\r\nAdenosine slows conduction through the AV node to restore normal sinus rhythm.\r\n

    Indications for Use<\/h3>\r\nAdenosine is used to treat paroxysmal supraventricular tachycardia.\r\n

    Nursing Considerations Across the Lifespan<\/h3>\r\nThis medication is an emergent type of medication. Use cautiously with geriatric clients who have decreased cardiac function.\r\n\r\nThis medication is contraindicated with clients who have 2nd or 3rd degree AV block, sinus node disease, or any known hypersensitivity.\r\n\r\nAt the time of administration, a nurse may see no electrical activity on an ECG for a brief few seconds before normal sinus rhythm is restored.\u00a0 It is important to warn the client about the potential for an extremely uncomfortable feeling during this short period of time.\r\n

    Adverse\/Side Effects<\/h3>\r\nClients receiving adenosine may experience prolonged asystole, arrhythmias, palpitations, facial flushing, hypotension, bronchospasm, shortness of breath, dizziness, seizures, loss of consciousness, numbness, tingling to upper extremities, and nausea.[footnote]This work is a derivative of Daily Med<\/a> by the U.S. National Library of Medicine<\/a> in the public domain<\/a>. [\/footnote]\r\n

    Client Teaching & Education<\/h3>\r\nClients should be advised to closely follow the recommended dosing regimen. Clients or family members may need instruction on how to take a pulse rate and should report any abnormalities.\u00a0 Clients should also be advised that this medication may cause dizziness and visual changes.\u00a0 Clients may also notice orthostatic blood pressure decrease with position changes and should be advised to change positions slowly.\r\n\r\nClients should be advised to avoid grapefruit juice during medication therapy.\u00a0 They should also monitor for gingival sensitivity and be sure to maintain good oral hygiene.\u00a0 Clients may also notice increased photosensitivity and should take protective measures.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n

    Class III - Potassium Channel Blockers<\/h2>\r\nClass III medications prolong repolarization by blocking the potassium channels in cardiac cells that are responsible for repolarization. They are used for emergency treatment of ventricular dysrhythmias. Amiodarone is an example of an antidysrhythmic that has predominantly Class III properties.\r\n

    Mechanism of Action<\/h3>\r\nClass III medications prolong repolarization by blocking the potassium channels in cardiac cells that are responsible for repolarization. Amiodarone also antagonizes alpha and beta receptors.\r\n

    Indications for Use<\/h3>\r\nAmiodarone is indicated only for the treatment of life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated.\r\n

    Nursing Considerations Across the Lifespan<\/h3>\r\nAmiodarone can cause fetal injury when administered to a pregnant client. Use cautiously with the geriatric population who may have decreased hepatic, cardiac, or renal function. Read drug label information carefully due to several potential drug interactions.\r\n

    Adverse\/Side Effects<\/h3>\r\nBlack Box Warnings: Amiodarone has several fatal toxicities such as pulmonary toxicity, exacerbation of arrhythmia, liver injury, and heart block. Clients who require initiation of this therapy should be hospitalized and monitored closely. Neurological impairments (such as fatigue, tremors, involuntary movements, poor coordination, and gait) and GI disturbances are common adverse effects. Vision changes\/loss of vision and photosensitivity may also occur.\r\n

    Client Teaching & Education<\/h3>\r\nClients should be advised to closely follow the recommended dosing regimen.\u00a0 If one dose of medication is missed, the client should follow the normal dosing schedule and resume with the next dose.\u00a0 If more than one dose of medication is missed, the client should call the healthcare provider for guidance. Clients should be compliant with all follow-up appointments and monitoring.\r\n\r\nClients should avoid drinking grapefruit juice during medication therapy.\u00a0 Some clients may experience photosensitivity and protective measures should be taken.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n

    Amiodarone Medication Card<\/h1>\r\nNow let's take a closer look at the medication card for amiodarone. [footnote]This work is a derivative of Daily Med<\/a> by the\u00a0U.S. National Library of Medicine<\/a>\u00a0in the\u00a0public domain<\/a>. [\/footnote] Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n
    \r\n

    Medication Card 6.6.1: Amiodarone<\/h2>\r\n<\/header>\r\n
    \r\n\r\nClass: <\/strong>Antiarrhythmic\r\n\r\nPrototypes: <\/strong>Amiodarone\r\n\r\nMechanism: <\/strong>Acts on myocardial depolarization and also repolarization. It blocks potassium, sodium and calcium channels as well as beta and alpha adrenergic receptors. Effects on electrical signals of the heart\r\n

    Therapeutic Effects<\/h3>\r\n